867 related articles for article (PubMed ID: 18389514)
41. cycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery system.
Meier C; Lorey M; De Clercq E; Balzarini J
J Med Chem; 1998 Apr; 41(9):1417-27. PubMed ID: 9554875
[TBL] [Abstract][Full Text] [Related]
42. New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.
Vlieghe P; Bihel F; Clerc T; Pannecouque C; Witvrouw M; De Clercq E; Salles JP; Chermann JC; Kraus JL
J Med Chem; 2001 Mar; 44(5):777-86. PubMed ID: 11262088
[TBL] [Abstract][Full Text] [Related]
43. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
44. Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
Abe H; Satoh M; Miyauchi S; Shuto S; Matsuda A; Kamo N
Bioconjug Chem; 1999; 10(1):24-31. PubMed ID: 9893960
[TBL] [Abstract][Full Text] [Related]
45. Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine.
Jin Y; Qi N; Tong L; Chen D
Int J Pharm; 2010 Feb; 386(1-2):268-74. PubMed ID: 19941945
[TBL] [Abstract][Full Text] [Related]
46. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro.
Siccardi D; Gumbleton M; Omidi Y; McGuigan C
Eur J Pharm Sci; 2004 May; 22(1):25-31. PubMed ID: 15113580
[TBL] [Abstract][Full Text] [Related]
47. Cyclization-activated prodrugs. Synthesis, reactivity and toxicity of dipeptide esters of paracetamol.
Santos C; Mateus ML; dos Santos AP; Moreira R; de Oliveira E; Gomes P
Bioorg Med Chem Lett; 2005 Mar; 15(6):1595-8. PubMed ID: 15745804
[TBL] [Abstract][Full Text] [Related]
48. AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems.
Liotard JF; Mehiri M; Di Giorgio A; Boggetto N; Reboud-Ravaux M; Aubertin AM; Condom R; Patino N
Antivir Chem Chemother; 2006; 17(4):193-213. PubMed ID: 17066898
[TBL] [Abstract][Full Text] [Related]
49. A step further in the SATE mononucleotide prodrug approach.
Peyrottes S; Villard AL; Coussot G; Augustijns P; Lefebvre I; Aubertin AM; Gosselin G; Périgaud C
Nucleic Acids Symp Ser (Oxf); 2008; (52):539-40. PubMed ID: 18776492
[TBL] [Abstract][Full Text] [Related]
50. The DiPPro approach: synthesis, hydrolysis, and antiviral activity of lipophilic d4T diphosphate prodrugs.
Schulz T; Balzarini J; Meier C
ChemMedChem; 2014 Apr; 9(4):762-75. PubMed ID: 24616176
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and preliminary evaluation of anti-HIV agent AZT prodrug.
Cui QB; Zhang GX; Yu P; Wang YQ
Yao Xue Xue Bao; 2011 Aug; 46(8):1015-8. PubMed ID: 22007530
[TBL] [Abstract][Full Text] [Related]
52. Poly(HEMA-Zidovudine) conjugate: a macromolecular pro-drug for improvement in the biopharmaceutical properties of the drug.
Neeraj A; Chandrasekar MJ; Sara UV; Rohini A
Drug Deliv; 2011 May; 18(4):272-80. PubMed ID: 21110710
[TBL] [Abstract][Full Text] [Related]
53. Primaquine dipeptide derivatives bearing an imidazolidin-4-one moiety at the N-terminus as potential antimalarial prodrugs.
Vale N; Nogueira F; do Rosário VE; Gomes P; Moreira R
Eur J Med Chem; 2009 Jun; 44(6):2506-16. PubMed ID: 19232784
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and in vitro biological evaluation of valine-containing prodrugs derived from clinically used HIV-protease inhibitors.
Roche D; Greiner J; Aubertin AM; Vierling P
Eur J Med Chem; 2008 Jul; 43(7):1506-18. PubMed ID: 17950955
[TBL] [Abstract][Full Text] [Related]
56. Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure.
Turk G; Moroni G; Pampuro S; Briñón MC; Salomón H
Int J Antimicrob Agents; 2002 Oct; 20(4):282-8. PubMed ID: 12385685
[TBL] [Abstract][Full Text] [Related]
57. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.
Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE
J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247
[TBL] [Abstract][Full Text] [Related]
58. Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.
Hubatsch I; Arvidsson PI; Seebach D; Luthman K; Artursson P
J Med Chem; 2007 Oct; 50(21):5238-42. PubMed ID: 17887660
[TBL] [Abstract][Full Text] [Related]
59. New 3'-azido-3'-deoxythymidin-5'-yl O-(4-hydroxyalkyl or -alkenyl or -alkylepoxide) carbonate prodrugs: synthesis and anti-HIV evaluation.
Vlieghe P; Clerc T; Pannecouque C; Witvrouw M; De Clercq E; Salles JP; Kraus JL
J Med Chem; 2001 Aug; 44(18):3014-21. PubMed ID: 11520210
[TBL] [Abstract][Full Text] [Related]
60. New lipophilic derivatives of AZT and d4T 5'-phosphonates.
Shirokova EA; Jasko MV; Khandazhinskaya AL; Yanvarev DV; Skoblov YS; Pronayeva TR; Fedyuk NV; Pokrovsky AG; Kukhanova MK
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):981-5. PubMed ID: 14565326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
